Brain mapping software for neurosurgery gets TGA clearance

Sydney-headquartered neuroscience software developer Omniscient Neurotechnology (o8t) has received Therapeutic Goods Administration (TGA) clearance for its brain mapping platform Quicktome, along with clearance from the US FDA and Health Canada.

The technology, aimed at allowing neurosurgeons to visualise and understand a patient's brain networks prior to surgery, is part of the new field of ‘connectomics’, described as the understanding of brain connectivity in routine neurosurgical planning.

Posted in Australian eHealth

Tags: Omniscient

You need to log in to post comments. If you don't have a Pulse+IT website account, click here to subscribe.

Sign up for Pulse+IT eNewsletters

Sign up for Pulse+IT website access

For more information, click here.

Copyright © 2022 Pulse+IT Communications Pty Ltd
No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher.
Supported by Social Media Agency | pepperit